Abstract:The tumor suppressor PTEN plays a critical role in the regulation of multiple cellular processes that include survival, cell cycle, proliferation and apoptosis. PTEN is frequently mutated or deleted in various human cancer cells to promote tumorigenesis. PTEN is regulated by SUMOylation, but the SUMO E3 ligase involved in the SUMOylation of PTEN remains unclear. Here, we demonstrated that PIASxα is a SUMO E3 ligase for PTEN. PIASxα physically interacted with PTEN both in vitro and in vivo. Their interaction depended on the integrity of Phosphatase and C2 domains of PTEN, and the region of PIASxα comprising residues 134-347. PIASxα enhanced PTEN protein stability by reducing PTEN ubiquitination, while the mutation of PTEN SUMO1 conjugation sites neutralized the effect of PIASxα on PTEN protein half-life. Functionally, PIASxα, as a potential tumor suppressor, negatively regulated the PI3K-Akt pathway through stabilizing PTEN protein. Overexpression of PIASxα led to G0/G1 cell cycle arrest, thus triggered cell proliferation inhibition and tumor suppression, whereas PIASxα knockdown or deficiency in catalytic activity abolished the inhibition. Together, our studies suggest that PIASxα is a novel SUMO E3 ligase for PTEN and it positively regulates PTEN protein level in tumor suppression. PTEN (phosphatase and tensin homologue deleted on chromosome TEN) (1) is a well-defined tumor suppressor that plays a critical role in multiple cellular processes, such as cell proliferation, apoptosis, cell cycle arrest and genomic stability maintenance (2-7). PTEN is reduced in expression, deleted or mutated with high frequency in various types of human cancers and is considered to function as a tumor suppressor (8, 9). The classic function of PTEN is to inhibit the PI3K (phosphatidylinositol http://www.jbc.org/cgi/doi/10.1074/jbc.M113.508515 The latest version is at JBC Papers in Press. Published on December 16, 2013 as Manuscript M113.508515 Copyright 2013 by The American Society for Biochemistry and Molecular Biology, Inc. by gest on O cber 0, 2017 hp://w w w .jb.org/ D ow nladed from

Poly-ADP ribosylation of PTEN by tankyrases promotes PTEN degradation and tumor growth.

Regulation of the tumor suppressor PTEN by natural anticancer compounds

PTEN regulation by Akt-EGR1-ARF-PTEN axis.

ATP modulates PTEN subcellular localization in multiple cancer cell lines

PTEN/PTENP1: ‘Regulating the regulator of RTK-dependent PI3K/Akt signalling’, new targets for cancer therapy

Targeting PTEN Regulation by Post Translational Modifications

Pten Acetylation Modulates Its Interaction With Pdz Domain

The Interplay Of Phosphorylation And Ubiquitylation In The Regulation Of Pten

Inhibition of the AKT/mTOR pathway negatively regulates PTEN expression via miRNAs

Molecular Features of Phosphatase and Tensin Homolog (PTEN) Regulation by C-terminal Phosphorylation

PIASx α enhances SUMO 1 modification of PTEN as a SUMO E 3 ligase

Tankyrase Disrupts Metabolic Homeostasis and Promotes Tumorigenesis by Inhibiting LKB1-AMPK Signalling

Sumo1 Modification of Pten Regulates Tumorigenesis by Controlling Its Association with the Plasma Membrane

Nuclear PTEN Regulates Thymidylate Biosynthesis in Human Prostate Cancer Cell Lines

Essential Role of AKT-1/Protein Kinase Bα in PTEN-Controlled Tumorigenesis

PTEN Dual Lipid- and Protein-Phosphatase Function in Tumor Progression

Ubiquitination Regulates Pten Nuclear Import and Tumor Suppression

The regulation of PTEN: Novel insights into functions as cancer biomarkers and therapeutic targets

Regulation of PARP1/2 and the tankyrases: emerging parallels

ATM-mediated PTEN Phosphorylation Promotes PTEN Nuclear Translocation and Autophagy in Response to DNA-damaging Agents in Cancer Cells.

PTENε Suppresses Tumor Metastasis Through Regulation of Filopodia Formation.